Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0Q1LO
|
|||
| Former ID |
DIB015702
|
|||
| Drug Name |
Sitamaquine
|
|||
| Synonyms |
WR-006026; WR-6026
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Infectious disease [ICD-11: 1A00-CA43.1; ICD-9: 001-139] | Phase 2 | [1] | |
| Company |
GlaxoSmithKline; Walter Reed Army Institute of Research
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C21H33N3O
|
|||
| Canonical SMILES |
CCN(CC)CCCCCCNC1=CC(=CC2=C(C=CN=C12)C)OC
|
|||
| InChI |
1S/C21H33N3O/c1-5-24(6-2)14-10-8-7-9-12-22-20-16-18(25-4)15-19-17(3)11-13-23-21(19)20/h11,13,15-16,22H,5-10,12,14H2,1-4H3
|
|||
| InChIKey |
RVAKDGYPIVSYEU-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 57695-04-2
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00381394) A Study Evaluating Sitamaquine Compared With Amphotericin B In The Treatment Of Visceral Leishmaniasis.. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.